Biomarker Driven Treatment of Selected NSCLC: EGFR. EGFR TKI in Mutant EGFR NSCLC. Mechanisms of Resistance and New Generation EGFR TKI.

Event ESMO Preceptorship on NSCLC Singapore December 2016
Session Session 4 Biomarker Driven Treatment
Topics Non-Small Cell Lung Cancer
Translational Research
Basic Principles in the Management and Treatment (of cancer)
Presenter J. Bennouna, FR